Foxp3 expressing regulatory T-cells in allergic disease

Area of Science:

• Immunology
• Allergology
• Cellular Biology

Background:

• Allergic diseases like asthma and eczema are globally increasing, impacting up to 20% of populations, especially in industrialized nations.
• Regulatory T-cells (Tregs), including CD4+CD25+ Tregs and IL-10-producing Tr1 cells, are vital for immune homeostasis, preventing autoimmunity, and suppressing allergic responses.
• Treg function relies on cell-cell contact and soluble cytokines (TGF-beta, IL-10), with the transcription factor Foxp3 being critical for their suppressive capabilities.

Purpose of the Study:

• To review the critical role of regulatory T-cells (Tregs) in maintaining immune tolerance and preventing immune-mediated diseases.
• To explore the mechanisms by which Tregs suppress immune responses, particularly in the context of allergic diseases.
• To discuss the potential of Treg-based therapies for treating conditions like allergic asthma, autoimmune diseases, and transplant rejection.

Main Methods:

• Review of existing literature on regulatory T-cells (Tregs), their subsets (CD4+CD25+ Tregs, Tr1 cells), and their suppressive mechanisms.
• Analysis of the role of transcription factor Foxp3 in Treg function.
• Examination of clinical evidence linking allergen immunotherapy to Treg induction and suppression of Th2 cytokines.

Main Results:

• Adoptive transfer of Tregs in animal models confirmed their efficacy in preventing and treating autoimmune conditions.
• Clinical improvements in allergic diseases correlate with the induction of IL-10 and TGF-beta producing Tr1 cells and Foxp3+ Tregs.
• Treg activity effectively suppresses the Th2 cytokine milieu associated with allergic inflammation.

Conclusions:

• Regulatory T-cells (Tregs) are essential for immune tolerance and preventing allergic and autoimmune diseases.
• Activating and expanding antigen-specific Tregs in vivo using adjuvants or pharmacological agents presents a promising therapeutic strategy.
• Treg-based approaches hold potential for inducing antigen-specific tolerance in immune-mediated conditions, including allergic asthma, autoimmune disorders, and organ transplantation.